These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison of renin-angiotensin to calcium channel blockade in renal disease. Tikkanen I; Johnston CI Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414 [TBL] [Abstract][Full Text] [Related]
12. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678 [TBL] [Abstract][Full Text] [Related]
13. Learning experiences from UNC. Renal autoregulation, drugs, and acute renal failure. Blythe WB N C Med J; 1985 Jul; 46(7):413-4. PubMed ID: 2993929 [No Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibition in renovascular hypertension: the narrowing gap between functional renal failure and progressive renal atrophy. Hricik DE J Lab Clin Med; 1990 Jan; 115(1):8-9. PubMed ID: 2299259 [No Abstract] [Full Text] [Related]
15. [Renal function after administration of angiotensin-converting enzyme inhibitors]. Waeber B; Burnier M; Nussberger J; Brunner HR Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075 [TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension. Thöne-Reineke C; Olivier J; Godes M; Zart R; George I; Bauer C; Neumayer HH; Hocher B Clin Sci (Lond); 2003 Jan; 104(1):79-85. PubMed ID: 12519090 [TBL] [Abstract][Full Text] [Related]